Fig. 1From: Significance of the urokinase-type plasminogen activator and its receptor in the progression of focal segmental glomerulosclerosis in clinical and mouse modelsModerate correlation between human plasma soluble urokinase-type plasminogen activator (uPA) receptor (suPAR) and serum creatinine in combination of FSGS (red) and MCD (blue) clinical casesBack to article page